CDC&P: MMWR Vol. 66 / Early Release

MMWR Early Release Vol. 66, Early Release July 07, 2017   PDF   In this report High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine Lucy A. McNamara, PhD; Nadav Topaz, MSc; Xin Wang, PhD; et al. Sixteen cases of meningococcal disease were identified in eculizumab recipients in the United States for the period 2008–2016. MMWR Masthead Stay up-to-date with the "voice of CDC" by downloading the MMWR Express app for fast access to MMWR: https://www.cdc.gov/mmwr/mmwr_mobileapps.html.   Department of Health and Human Services Centers for Disease Control and Prevention The CDC has reached over 1.3 million subscribers. Thank you for your support.                This email was sent using GovDelivery Communications Cloud on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636)